A retrospective study of clinical use of recombinant human erythropoietin for treatment of anemia in dogs with renal failure in Bangkok, Thailand

2008 ◽  
Vol 17 (3) ◽  
pp. 165-170
Author(s):  
Sukullaya Assarasakorn ◽  
Morakot Kaewthamasorn ◽  
Anuchai Niwetpathomwat
1992 ◽  
Vol 30 (8) ◽  
pp. 29.2-32

Erythropoietin is the endogenous hormone controlling red blood cell production. Most is made in the kidneys; if they fail, erythropoietin levels fall and anaemia develops. Treatment of erythropoietin deficiency anaemia in patients with renal failure has depended on repeated blood transfusions. Despite transfusions most patients remain anaemic and in addition are exposed to the risks of transfusion, such as viral infection, iron overload and problems associated with red cell antibody formation. The erythropoietin gene has been cloned and recombinant human erythropoietin (rHuEPO) is now marketed under the generic name epoetin. In this article we discuss the use of epoetin to treat anaemia in patients with renal failure and other potentially responsive conditions.


1990 ◽  
Vol 89 (4) ◽  
pp. 432-435 ◽  
Author(s):  
Alan J. Watson ◽  
Luis F. Gimenez ◽  
Sandra Cotton ◽  
Mackenzie Walser ◽  
Jerry L. Spivak

1992 ◽  
Vol 6 (3) ◽  
pp. 277-277
Author(s):  
J. H. C. Evans ◽  
J. T. Brocklebank ◽  
C. J. Bowmer ◽  
P. C. Ng

Biotherapy ◽  
1990 ◽  
Vol 2 (1) ◽  
pp. 77-85 ◽  
Author(s):  
Akinori Kawamura ◽  
Masato Higuchi ◽  
Nobuo Imai ◽  
Tsutomu Kawaguchi ◽  
Yohsuke Ogura

2004 ◽  
Vol 66 (7) ◽  
pp. 883-886 ◽  
Author(s):  
Misuzu YAMAGUCHI-YAMADA ◽  
Noboru MANABE ◽  
Yasufumi GOTO ◽  
Sayuri ANAN ◽  
Keiko MIYAMOTO ◽  
...  

Injury ◽  
2012 ◽  
Vol 43 (3) ◽  
pp. 367-373 ◽  
Author(s):  
Fwu-Lin Yang ◽  
Yi-Maun Subeq ◽  
Yi-Han Chiu ◽  
Ru-Ping Lee ◽  
Chung-Jen Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document